What happens if you stop taking GLP-1?

It’s common for GLP-1 treatment to stop

GLP-1 medicines have been shown to have a stronger effect than many traditional treatments, both for blood sugar control and for weight loss. In clinical trials, some medicines have been linked to weight loss of around 15 to 20 percent after one year of treatment.

Even so, many people choose to stop treatment. Real world studies show that stopping is common. In some groups, more than half of people living with obesity without diabetes discontinue treatment.

This tells us that good results alone are not always enough to support long term use. Things like side effects, expectations, access, cost and the right support all play a big part in whether treatment continues.

Common reasons for stopping include:

• Ongoing digestive side effects, without knowing there may be alternative options
• Believing the treatment is temporary and that weight loss will stay the same after stopping
• High cost
• Feeling stuck at a weight plateau and assuming the treatment is no longer working, without knowing there may be other strategies to try

What happens when treatment stops?

It’s common for weight to start increasing again after GLP-1 treatment is stopped. This isn’t about a lack of motivation or “doing something wrong”. It’s about biology.

When the medication is withdrawn, the biological systems that regulate weight, hunger and fullness begin to shift. Many people notice that hunger and food cravings gradually return.

Overweight and obesity are recognised as chronic conditions. The body often works hard to defend its weight through complex biological mechanisms. Whenever weight is lost, no matter how, the body activates processes designed to restore the previous weight. This can mean:

• Stronger hunger signals
• Reduced feelings of fullness
• A metabolism that becomes more energy efficient

Together, these changes can make it harder to maintain weight loss over time.

GLP-1 medicines help to dampen these biological signals. When treatment stops, the body’s counter mechanisms can become more noticeable again, increasing the risk of weight regain. Research shows that many people regain a significant proportion of the weight they’ve lost, especially if there isn’t continued lifestyle and behavioural support in place.

That said, weight regain varies from person to person. It’s influenced by factors such as medical history, length of treatment and the level of follow up and support. Even if two people start from a similar place, their biological response and tolerance to treatment can differ. That’s why personalised planning and ongoing review are so important.

Appetite and hunger during GLP-1 treatment

One of the most noticeable effects people describe on GLP-1 treatment is a calmer appetite. Fullness tends to come sooner. Portion sizes often reduce naturally. Cravings feel less intense, often without the same level of effort as before.

This happens because GLP-1 affects appetite regulation in the brain and slows the emptying of the stomach.

When treatment stops, appetite and hunger can gradually change again. Hunger signals may return and feel stronger, especially if you’ve become used to feeling full on smaller amounts of food.

You might notice:

• More snacking urges between meals
• Larger portion sizes
• Fullness arriving later or feeling weaker
• More frequent thoughts about food

These changes are not a sign of poor discipline or low motivation. They reflect how your body’s biological appetite regulation responds when hormonal support from treatment is reduced or removed.

Metabolic changes after stopping GLP-1

Research also shows that metabolic markers can shift after treatment ends. Blood sugar control may worsen, and increases in glucose levels, HbA1c, waist measurement and blood pressure have been reported, particularly in people who already had metabolic challenges.

Other markers linked to metabolic health may also gradually change once the medication effect is no longer present.

Again, these changes vary between individuals. They depend on starting point, treatment duration and lifestyle factors. Overall, current evidence suggests that the benefits of GLP-1 treatment are closely linked to ongoing use, and stopping is often followed by a gradual return towards previous physiological levels.

Understanding this can help set realistic expectations and make sure the right support and strategies are in place if challenges arise.

Important things to consider before stopping

Before deciding to stop GLP-1 treatment, it’s important to carefully weigh up the potential benefits and risks. When treatment ends, the body’s previous biological mechanisms can reactivate. This often means a higher risk of weight regain and, for some people, a worsening of metabolic balance.

Stopping can also affect emotional wellbeing. Many people feel anxious about losing the progress they’ve made or frustrated if weight starts to increase again. These reactions are common and completely understandable.

Stopping treatment is rarely about a lack of willpower. It may be linked to uncertainty about side effects, misunderstandings about how long treatment is meant to last, or a feeling that the effect has worn off.

In many cases, there may be alternative approaches or dose adjustments that could improve both tolerance and outcomes, but you might not be aware of them. That’s why open dialogue and proper follow up are so important before making a decision.

Stopping GLP-1 medication is a big step. It’s wise to make that decision together with your doctor, so you can talk through the risks and options in a balanced way.

What if you’ve reached your target weight?

Another common reason for stopping treatment is reaching a target weight. That’s a real milestone. You might feel proud, relieved, or even a bit uncertain about what comes next.

For many people, the hardest part of weight treatment isn’t losing weight. It’s maintaining the new, lower weight. The body naturally tries to return to a higher weight by increasing appetite and reducing energy expenditure.

Medication as ongoing support

For some people, continuing medication after reaching a target weight may be appropriate. Based on what we know today, there isn’t yet a clear answer about how long maintenance treatment should last. For some, it may be longer term.

Studies showing that hunger, weight and metabolic balance tend to shift back after stopping treatment support the view that obesity is a chronic disease. It isn’t about weak character or lack of effort.

Once a stable weight has been reached, the dose is usually adjusted in discussion with your doctor. The aim is to find the lowest effective dose, often called a maintenance dose, where appetite, hunger and cravings feel manageable and weight can remain stable.

How to maintain your weight long term

The National Weight Control Registry in the United States is the largest registry in the world tracking people who have lost weight and successfully kept it off. Research suggests that people who maintain weight loss over time often share several behaviours:

• Keeping energy intake moderate and increasing calories gradually if needed
• Eating regularly, at similar times each day, including weekends
• Eating breakfast daily, with a balanced meal that supports steadier eating later in the day
• Choosing nutrient dense foods such as vegetables, pulses, wholegrains, fish, eggs and chicken, and limiting foods high in energy but low in nutrients, such as sweets, pastries and alcohol
• Weighing themselves regularly, for example once a week, even after reaching target weight
• Keeping a food diary at times to stay aware of intake
• Staying physically active every day. On average, people who maintain weight loss report around 60 minutes of activity daily

These patterns aren’t about perfection. They’re about building routines that make weight stability more realistic over time.

Summary

Obesity is now recognised as a chronic disease. The body actively defends its weight through biological mechanisms. Research and clinical experience show that appetite, hunger and metabolic balance often shift back when GLP-1 treatment is stopped. This reinforces the understanding that, for many people, treatment is not a short term fix but part of managing a long term condition, much like other chronic diseases.

For some, medication may need to continue even after a target weight is reached. We still don’t have clear answers about how long maintenance treatment should last. For some individuals, it may be long term. This is not a failure. It reflects the biological nature of the condition, not a lack of willpower or motivation.

When weight is stable, treatment is usually managed in partnership with a doctor. The dose can be adjusted to the lowest effective maintenance level, with the aim of keeping appetite and cravings manageable and weight stable over time. Ongoing lifestyle support and regular follow up remain important parts of long term health and wellbeing.

Common questions about stopping GLP-1 medication

Will I always regain weight?
No, not always. However, research shows that weight regain is common after stopping GLP-1 treatment, especially without a clear plan and continued support. Many people regain some of the weight, but the amount varies from person to person.

Why does hunger feel stronger?
GLP-1 medicines reduce hunger and increase fullness. When treatment stops, the body’s appetite regulation gradually shifts back. The body may increase hunger signals and reduce fullness in an effort to defend weight, which can make hunger feel stronger.

Sources

European Society of Cardiology (ESC). Obesity and Cardiovascular Disease: an ESC Clinical Consensus Statement.
https://academic.oup.com/eurheartj/article/45/38/4063/7738070

Diabetes, Obesity and Metabolism. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension.
https://pubmed.ncbi.nlm.nih.gov/35441470/

BMJ. Weight Regain After Cessation of Weight Management Medications: Systematic Review and Meta-Analysis.
https://www.bmj.com/content/392/bmj-2025-085304

eClinicalMedicine. Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. 2025.
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00614-5/fulltext

American Journal of Clinical Nutrition. Long term weight loss maintenance. Wing RR, Phelan S. 2005.
https://pubmed.ncbi.nlm.nih.gov/16002825/

American Journal of Clinical Nutrition. A descriptive study of individuals successful at long term maintenance of substantial weight loss. Klem ML et al. 1997.
https://pubmed.ncbi.nlm.nih.gov/9250100/

‍